Identification and therapeutic evaluation of ALK rearrangements in non‐small‐cell lung cancer
Author:
Affiliation:
1. Department of Pathology, Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai PR China
2. Department of Pulmonary, Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai PR China
Funder
Health and Family Planning Commission of Sichuan Province
Publisher
Wiley
Subject
Pathology and Forensic Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cjp2.289
Reference30 articles.
1. ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time
2. Targeting ALK: Precision Medicine Takes on Drug Resistance
3. The inhibition of anaplastic lymphoma kinase in non-small cell lung tumours with the ALK rearrangement may result in tumour shrinkage
4. Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non–Small-Cell Lung Cancer
5. Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of myofibroblasts in oral plasma cell granuloma: Immunohistochemical evaluation of α-SMA and ALK in a retrospective study of 30 cases;Journal of Stomatology, Oral and Maxillofacial Surgery;2023-12
2. A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma;Translational Lung Cancer Research;2023-07
3. Replacement of ALK inhibitors as an effective strategy for reducing drug toxicity in non-small cell lung cancer patients with ALK gene rearrangement;Oncology in Clinical Practice;2023-06-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3